NP Life Sciences Health Industry Group Inc. ACAT
NP Life Sciences Health Industry Group Inc. (ACAT) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2023 revenue was $164,621 at a -1.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 1013 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ACAT | NP Life Sciences Health Industry Group Inc. | 3/9 | — | — | — |
| VSA | VisionSys AI Inc | 3/9 | -10.75 | — | -99.9% |
| RMGL | Rocky Mountains Group Ltd | 3/9 | -13.4 | — | — |
| EDTK | Skillful Craftsman Education Technology Ltd | 3/9 | — | — | — |
| RPDL | Rapid Line Inc. | 2/9 | — | — | — |
| DWAY | Driveitaway Holdings, Inc. | 2/9 | — | — | — |
| KPEA | Kun Peng International Ltd. | 3/9 | — | — | — |
About NP Life Sciences Health Industry Group Inc.
Acasia Technology, Inc., technology development company, develops various entertainment experiences. It provides players and creators with the tools to design, explore, and share interactive worlds. The company's platform integrates AI-powered content generation, dynamic gameplay systems, and robust social connectivity features to a digital ecosystem. Acasia Technology, Inc. was formerly known as NP Life Sciences Health Industry Group Inc. and changed its name to Acasia Technology, Inc. in May 2025. The company was incorporated in 2018 and is based in Minneapolis, Minnesota.
FAQ
Is ACAT financially healthy?
NP Life Sciences Health Industry Group Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does ACAT pay a dividend?
No, NP Life Sciences Health Industry Group Inc. does not currently pay a dividend.
How profitable is ACAT?
In FY2023, NP Life Sciences Health Industry Group Inc. had a net margin of -1.8% and a return on equity of -17.9%.
Is ACAT a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on NP Life Sciences Health Industry Group Inc.: a Piotroski F-score of 3/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.